**The big picture:** Contract-to-hire models are rapidly expanding as industries like life sciences shift to mitigate hiring risks, with contract job postings surging significantly compared to full-time roles. This indicates a deliberate industry-wide repricing of talent acquisition risk. **Why it matters:** Staffing and corporate leaders must strategically deploy contract-to-hire to secure talent and manage costs effectively, as its misuse can deter top candidates and create unforeseen risks. **Between the lines:** - Life sciences contract postings jumped 94% in a year (BioSpace Q1 2026). - ASA data shows 9.5M temp/contract workers in 2025, with Q1 2026 showing stabilization after a contraction. - Effective for uncertain demand, new roles, frozen headcount, and mutual evaluation; ineffective for senior or cleared talent. **Staffing & HR impact:** Staffing firms can capitalize on demand for flexible solutions, but recruiters must advise clients on appropriate use to maintain candidate quality and avoid margin erosion from failed placements. HR leaders need clear policies to prevent alienating critical talent. **The bottom line:** Contract-to-hire is a potent risk management tool, but its efficacy is entirely dependent on its judicious application to specific hiring scenarios and talent pools.